Table 2: Demographic characteristics of the CanIMPACT provincial breast cancer cohorts (%).
BC | AB | MB | ON | NS | |
---|---|---|---|---|---|
Overall N | 14,198 | 12,373 | 4,216 | 46,966 | 3,802 |
Diagnosis years | 2007-2011 | 2004-2010 | 2007-2012 | 2007-2012 | 2007-2012 |
Stage | |||||
In Situ (Alberta Only) | NA | 12.8 | NA | NA | NA |
I | 42.0 | 38.8 | 40.5 | 37.2 | 44.2 |
II | 32.0 | 30.9 | 37.5 | 35.4 | 33.4 |
III | 12.7 | 12.0 | 14.3 | 13.0 | 12.6 |
IV | 4.2 | 3.3 | 6.1 | 4.4 | 6.1 |
Unknown | 9.0 | 3.1 | 1.6 | 10.0 | 3.7 |
Histologic Grade | |||||
Well differentiated | 20.5 | 19.1 | 19.2 | 10.9 | 16.6 |
Moderately differentiated | 37.7 | 40.2 | 42.9 | 22.7 | 38.0 |
Poorly or undifferentiated | 31.7 | 35.6 | 29.4 | 15.9 | 35.8 |
Unknown | 10.2 | 5.1 | 8.4 | 50.4 | 9.6 |
Co-morbidity (ACG System-ADGs) | |||||
0-3 ADGs | 32.1 | NA | 23.6 | 26.4 | 21.9 |
4-5 ADGs | 24.3 | 22.5 | 22.8 | 20.9 | |
6-7 ADGs | 19.7 | 20.4 | 21.1 | 20.2 | |
8-9 ADGs | 12.9 | 16.2 | 15.0 | 16.7 | |
10+ ADGs | 11.0 | 17.3 | 14.8 | 20.3 | |
Co-morbidity (ACG System-RUBs) | |||||
0 (no or invalid diagnosis) | 5.8 | NA | 3.6 | 4.8 | 4.0 |
1 (healthy user) | 2.4 | 3.8 | 2.7 | 2.1 | |
2 (low) | 12.5 | 10.7 | 11.0 | 9.0 | |
3 (moderate) | 60.2 | 58.8 | 58.5 | 58.9 | |
4 (high) | 13.6 | 16.9 | 16.5 | 18.3 | |
5 (very high) | 5.5 | 6.2 | 6.5 | 7.6 |